IRON - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan discmedicine.com

The EV/EBITDA valuation trend reflects market expectations, with the latest value recorded as 0.00. The success of Disc Medicine, Inc. (IRON) is based on clinical test results and patent support. Production capacities and laboratories operate strictly according to regulations. Large-scale investments in cellular therapy for anemia create a serious foundation for technological dominance in the blood cancer treatment segment.

IRON Disc Medicine Corp: Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ing interval 23.11.2025 - 14.11.2026

discmedicine.com - rincian analitis lan metrik utama (IRON)

- rega saiki lan proyeksi nilai saham:

Rega saham Disc Medicine Corp|IRON - Bagan rega target

- statistik kapitalisasi pasar:

Nilai pasar Disc Medicine Pharma|IRON - Nilai Total Perusahaan

- indikator nilai buku ekuitas:

Aset Bersih saben Siji Saham Disc Medicine|IRON - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku discmedicine.com|IRON - Aset Perusahaan

- rincian struktur utang lan likuiditas bisnis:

Total Utang marang Modal Disc Medicine, Inc.|IRON - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal Disc Medicine|IRON - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Disc Medicine Pharma|IRON - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Disc Medicine|Rasio cepet discmedicine.com

- data bathi bisnis lan rasio investasi:

IRON - Penghasilan resik|Bathi mangsa ngarep Disc Medicine, Inc.|IRON - Nilai perusahaan marang bathi resik|Rega marang bathi mangsa ngarep Disc Medicine, Inc.|IRON - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Disc Medicine Pharma|IRON - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Disc Medicine|IRON - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan discmedicine.com|IRON - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Disc Medicine, Inc.

- rincian pendapatan lan dodolan:

IRON - Dodolan perusahaan|Prakiraan volume dodolan Disc Medicine Corp|IRON - Koefisien rega marang pendapatan|Rasio rega marang prakiraan pendapatan Disc Medicine Pharma

Pambiji fundamental perusahaan:Disc Medicine Corp IRON

To identify fundamental benchmarks in the financial statements of Disc Medicine, Inc. (IRON), it is critical to analyze the real value of assets relative to operational efficiency. The EV/EBITDA trend for the business reflects the ratio of the company's total enterprise value to earnings before interest, taxes, depreciation, and amortization, allowing for an assessment of the capital intensity involved in developing treatments for anemia and rare blood pathologies while accounting for the debt load.

Analisis perusahaan pesaing